CTI BIOPHARMA CORP·4

Apr 7, 6:25 PM ET

Parkinson David Ross 4

4 · CTI BIOPHARMA CORP · Filed Apr 7, 2023

Insider Transaction Report

Form 4
Period: 2023-04-05
Transactions
  • Award

    Stock Option (right to buy)

    2023-04-05+80,00080,000 total
    Exercise: $4.08Exp: 2033-04-05Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2024 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION